本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Clearmind Medicine, Inc.

1.16
-0.5400-31.76%
盤後1.190.0300+2.59%19:59 EDT
成交量:1,551.24萬
成交額:2,892.20萬
市值:172.32萬
市盈率:-0.01
高:1.56
開:1.50
低:1.16
收:1.70
52周最高:524.00
52周最低:1.16
股本:148.56萬
流通股本:147.60萬
量比:72.32
換手率:1051.01%
股息:- -
股息率:- -
每股收益(TTM):-175.9200
每股收益(LYR):-303.4772
淨資產收益率:-114.61%
總資產收益率:-51.35%
市淨率:0.15
市盈率(LYR):0.00

資料載入中...

2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

SEC問詢函

Form CORRESP - Correspondence
2026/02/26

SEC問詢函

Form CORRESP - Correspondence
2026/01/20

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/12/09

SEC問詢函

Form CORRESP - Correspondence
2025/12/05

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2025/11/27

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/10/01

SEC問詢函

Form CORRESP - Correspondence
2025/09/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/01/22

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/27

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/03/19

SEC問詢函

Form CORRESP - Correspondence
2024/03/18

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/02/14

SEC問詢函

Form CORRESP - Correspondence
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

招股説明書

Form F-1 - Registration statement for certain foreign private issuers